247 related articles for article (PubMed ID: 17111035)
1. The effect of an adenosine and lidocaine intravenous infusion on myocardial high-energy phosphates and pH during regional ischemia in the rat model in vivo.
Canyon SJ; Dobson GP
Can J Physiol Pharmacol; 2006; 84(8-9):903-12. PubMed ID: 17111035
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
Canyon SJ; Dobson GP
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
[TBL] [Abstract][Full Text] [Related]
3. Blocking Na(+)-H+ exchange by cariporide reduces Na(+)-overload in ischemia and is cardioprotective.
Hartmann M; Decking UK
J Mol Cell Cardiol; 1999 Nov; 31(11):1985-95. PubMed ID: 10591025
[TBL] [Abstract][Full Text] [Related]
4. Different preconditioning stimuli invoke disparate electromechanical and energetic responses to global ischemia in rat hearts.
Rehring TF; Bender PR; Cairns CB; Joo K; Friese RS; Shapiro JI; Cleveland JC; Banerjee A
Can J Physiol Pharmacol; 1997 Apr; 75(4):335-42. PubMed ID: 9196860
[TBL] [Abstract][Full Text] [Related]
5. Effects of regional myocardial lidocaine infusion on high energy phosphates.
Schaefer S; Schwartz GG; Steinman S; Garcia J; Trocha SD; Weiner MW; Massie BM
J Mol Cell Cardiol; 1994 Dec; 26(12):1601-11. PubMed ID: 7731055
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone pretreatment effects on ischemic isovolumic rat hearts: a P-31 nuclear magnetic resonance study of intracellular pH and high-energy phosphates contents evolutions.
Vander Elst L; Goudemant JF; Mouton J; Chatelain P; Van Haverbeke Y; Muller RN
J Cardiovasc Pharmacol; 1990 Mar; 15(3):377-85. PubMed ID: 1691360
[TBL] [Abstract][Full Text] [Related]
7. Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat.
Canyon SJ; Dobson GP
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1286-95. PubMed ID: 15317678
[TBL] [Abstract][Full Text] [Related]
8. Ischemic preconditioning preserves end-ischemic ATP, enhancing functional recovery and coronary flow during reperfusion.
Kaplan LJ; Bellows CF; Blum H; Mitchell M; Whitman GJ
J Surg Res; 1994 Jul; 57(1):179-84. PubMed ID: 8041135
[TBL] [Abstract][Full Text] [Related]
9. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of lidocaine on the ischemic-reperfused rat heart: a phosphorus 31 nuclear magnetic resonance study.
Kojima M; Miura M
Basic Res Cardiol; 1991; 86 Suppl 1():179-87. PubMed ID: 2036091
[TBL] [Abstract][Full Text] [Related]
11. An inhibitor of poly (ADP-ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart.
Docherty JC; Kuzio B; Silvester JA; Bowes J; Thiemermann C
Br J Pharmacol; 1999 Jul; 127(6):1518-24. PubMed ID: 10455304
[TBL] [Abstract][Full Text] [Related]
12. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA).
Zhao L; Kirsch CC; Hagen SR; Elliott GT
J Mol Cell Cardiol; 1996 Jan; 28(1):197-208. PubMed ID: 8745227
[TBL] [Abstract][Full Text] [Related]
13. Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury.
Davani S; Vergely C; Royer B; Bouhaddi M; Reyssie H; Rochette L; Kantelip JP
Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL868-73. PubMed ID: 17543224
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide, and prostacyclin.
Zhu P; Zaugg CE; Simper D; Hornstein P; Allegrini PR; Buser PT
Cardiovasc Res; 1995 May; 29(5):658-63. PubMed ID: 7606754
[TBL] [Abstract][Full Text] [Related]
15. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.
Headrick JP
J Mol Cell Cardiol; 1996 Jun; 28(6):1227-40. PubMed ID: 8782064
[TBL] [Abstract][Full Text] [Related]
16. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization.
Prabhakar G; Vona-Davis L; Murray D; Lakhani P; Murray G
J Am Coll Surg; 2003 Nov; 197(5):786-91. PubMed ID: 14585415
[TBL] [Abstract][Full Text] [Related]
17. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
Vander Heide RS; Reimer KA
Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
[TBL] [Abstract][Full Text] [Related]
18. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia.
Woo YJ; Taylor MD; Cohen JE; Jayasankar V; Bish LT; Burdick J; Pirolli TJ; Berry MF; Hsu V; Grand T
J Thorac Cardiovasc Surg; 2004 May; 127(5):1262-9. PubMed ID: 15115981
[TBL] [Abstract][Full Text] [Related]
19. Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts.
Kobara M; Tatsumi T; Matoba S; Yamahara Y; Nakagawa C; Ohta B; Matsumoto T; Inoue D; Asayama J; Nakagawa M
J Mol Cell Cardiol; 1996 Feb; 28(2):417-28. PubMed ID: 8729072
[TBL] [Abstract][Full Text] [Related]
20. Real-time monitoring of cardiac metabolism using biosensors shows myocardial protection during ischemia-reperfusion injury with glucose-insulin-potassium administration.
Eiferman D; Perez-Tamayo RA; Abe K; Okum E; Higgins R
Surgery; 2007 Aug; 142(2):150-5. PubMed ID: 17689679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
